title: Famotidine reduces serum parathyroid hormone levels in uremic patients.
authors.forename: N
authors.initials: N
authors.lastname: Arik
authors.forename: T
authors.initials: T
authors.lastname: Arinsoy
authors.forename: M
authors.initials: M
authors.lastname: Sayín
authors.forename: I
authors.initials: I
authors.lastname: Taşdemir
authors.forename: U
authors.initials: U
authors.lastname: Yasavul
authors.forename: C
authors.initials: C
authors.lastname: Turgan
authors.forename: S
authors.initials: S
authors.lastname: Caglar
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood; D002118:Calcium / Q000097:blood; D015738:Famotidine / Q000627:therapeutic use*; D006801:Humans; D006961:Hyperparathyroidism / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D010281:Parathyroid Hormone / Q000097:blood*; D010710:Phosphates / Q000097:blood; D014511:Uremia / Q000097:blood / Q000150:complications*
chemical_list: D010281:Parathyroid Hormone; D010710:Phosphates; D015738:Famotidine; D000469:Alkaline Phosphatase; D002118:Calcium